{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:46:11Z","timestamp":1785757571497,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.msard.2026.106991","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:30:44Z","timestamp":1768235444000},"page":"106991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Altered serotonergic system and mood behaviors in a cuprizone-induced model of demyelination"],"prefix":"10.1016","volume":"108","author":[{"given":"Souhoudji Themoi","family":"Demsou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Ouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpha Amadou","family":"Bah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assma\u00e2","family":"Tali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja\u00e2","family":"Jebbouj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-7956","authenticated-orcid":false,"given":"Samir","family":"Ahboucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.106991_bib0001","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jneuroim.2013.06.012","article-title":"Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model","volume":"262","author":"Acs","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.106991_bib0002","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroscience.2013.06.009","article-title":"Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis","volume":"248","author":"Aminian","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.msard.2026.106991_bib0003","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1471-4159.2001.00437.x","article-title":"Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout","volume":"78","author":"Ase","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2026.106991_bib0004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.bbr.2013.06.019","article-title":"The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE)","volume":"252","author":"Benson","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.msard.2026.106991_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in multiple sclerosis: a systematic review and metaanalysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.106991_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102587","article-title":"Disruption of brainstem monoaminergic fiber tracts in multiple sclerosis as a putative mechanism for cognitive fatigue: a fixel-based analysis","volume":"30","author":"Carandini","year":"2021","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.msard.2026.106991_bib0007","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbr.2017.05.045","article-title":"Increased central dopaminergic activity might be involved in the behavioral abnormality of cuprizone-exposure mice","volume":"331","author":"Chang","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.msard.2026.106991_bib0008","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00213-008-1219-3","article-title":"Reduction in the anxiolytic effects of ethanol by centrally formed acetaldehyde: the role of catalase inhibitors and acetaldehyde sequestering agents","volume":"200","author":"Correa","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.msard.2026.106991_bib0009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2018.05.013","article-title":"The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination","volume":"1694","author":"Cui","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.msard.2026.106991_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/glia.23538","article-title":"Cuprizone-induced graded oligodendrocyte vulnerability is regulated by the transcription factor DNA damage-inducible transcript 3","volume":"67","author":"Fischbach","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.msard.2026.106991_bib0011","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1038\/s41598-017-04968-z","article-title":"Fluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model of multiple sclerosis","volume":"7","author":"Ghareghani","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.106991_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022623","article-title":"Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming","volume":"6","author":"Gudi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2026.106991_bib0013","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3758\/s13415-016-0449-9","article-title":"Linking major depression and the neural substrates of associative processing","volume":"16","author":"Harel","year":"2016","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"10.1016\/j.msard.2026.106991_bib0014","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00259-013-2636-z","article-title":"Altered serotonin transporter availability in patients with multiple sclerosis","volume":"41","author":"Hesse","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.msard.2026.106991_bib0015","doi-asserted-by":"crossref","DOI":"10.1042\/AN20090032","article-title":"Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination","volume":"1","author":"Hibbits","year":"2009","journal-title":"ASN Neuro."},{"key":"10.1016\/j.msard.2026.106991_bib0016","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.1523\/JNEUROSCI.1749-20.2020","article-title":"Ferroptosis mediates cuprizone-induced loss of oligodendrocytes and demyelination","volume":"40","author":"Jhelum","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.msard.2026.106991_bib0017","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0014-4800(71)90020-7","article-title":"Histopathologic and enzyme histochemical observations of the cuprizone-induced brain edema","volume":"15","author":"Kesterson","year":"1971","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.msard.2026.106991_bib0018","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/ptr.6327","article-title":"Plant polyprenols reduce demyelination and recover impaired oligodendrogenesis and neurogenesis in the cuprizone murine model of multiple sclerosis","volume":"33","author":"Khodanovich","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.msard.2026.106991_bib0019","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neures.2016.01.006","article-title":"Dimensional assessment of behavioral changes in the cuprizone short-term exposure model for psychosis","volume":"107","author":"Kondo","year":"2016","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.msard.2026.106991_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4939-8994-2_5","article-title":"The forced swim test for depression-like behavior in rodents","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.msard.2026.106991_bib0021","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/1516-4446-2018-0183","article-title":"From anatomy to function: the role of the somatosensory cortex in emotional regulation","volume":"41","author":"Kropf","year":"2019","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.msard.2026.106991_bib0022","doi-asserted-by":"crossref","first-page":"40","DOI":"10.31083\/j.jin2202040","article-title":"Effects of bone marrow mesenchymal stem cells on myelin repair and emotional changes of a cuprizone-induced demyelination model","volume":"22","author":"Lei","year":"2023","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.msard.2026.106991_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12277","article-title":"Wuzi Yanzong Pill relieves CPZ-induced demyelination by improving the microenvironment in the brain","volume":"8","author":"Li","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.msard.2026.106991_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154309","article-title":"Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair","volume":"106","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.msard.2026.106991_bib0025","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.pnpbp.2009.05.006","article-title":"Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice","volume":"33","author":"Makinodan","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.msard.2026.106991_bib0026","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2026.106991_bib0027","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11481-019-09852-3","article-title":"Dopaminergic therapeutics in multiple sclerosis: focus on Th17-cell functions","volume":"15","author":"Melnikov","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.msard.2026.106991_bib0028","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.3390\/ijms22137183","article-title":"Effects of venlafaxine, risperidone, and febuxostat on cuprizone-induced demyelination, behavioral deficits, and oxidative stress","volume":"22","author":"Mihai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.106991_bib0029","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3892\/etm.2022.11133","article-title":"Low-field magnetic stimulation improved cuprizone-induced depression-like symptoms and demyelination in female mice","volume":"23","author":"Mooshekhian","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.msard.2026.106991_bib0030","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.bbi.2011.06.011","article-title":"The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE)","volume":"25","author":"Musgrave","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.msard.2026.106991_bib0031","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00429-014-0924-4","article-title":"Conditional anterograde tracing reveals distinct targeting of individual serotonin cell groups (B5\u2013B9) to the forebrain and brainstem","volume":"221","author":"Muzerelle","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.msard.2026.106991_bib0032","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/cells8111363","article-title":"Laquinimod supports remyelination in non-supportive environments","volume":"8","author":"Nyamoya","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.msard.2026.106991_bib0033","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/brainsci12121687","article-title":"Sex differences in the behavioural aspects of the cuprizone-induced demyelination model in mice","volume":"12","author":"Paton","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.msard.2026.106991_bib0034","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbr.2011.01.018","article-title":"Inflammation modulates anxiety in an animal model of multiple sclerosis","volume":"220","author":"Peruga","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.msard.2026.106991_bib0035","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10571-021-01064-9","article-title":"The roles of serotonin in neuropsychiatric disorders","volume":"42","author":"Pourhamzeh","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.msard.2026.106991_bib0036","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.msard.2026.106991_bib0037","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2026.106991_bib0038","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/eji.201847525","article-title":"Serotonin decreases the production of Th1\/Th17 cytokines and elevates the frequency of regulatory CD4(+) T cell subsets in multiple sclerosis patients","volume":"48","author":"Sacramento","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.msard.2026.106991_bib0039","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fpsyt.2020.00381","article-title":"Associations among monoamine neurotransmitter pathways, personality traits, and major depressive disorder","volume":"11","author":"Shao","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.msard.2026.106991_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216113","article-title":"Clozapine administration enhanced functional recovery after cuprizone demyelination","volume":"14","author":"Templeton","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2026.106991_bib0041","article-title":"Hypothalamic neurons fully or partially expressing the dopaminergic phenotype: development, distribution, functioning and functional significance","volume":"75","author":"Ugrumov","year":"2024","journal-title":"A Rev. Front Neuroendocrinol."},{"key":"10.1016\/j.msard.2026.106991_bib0042","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/jnr.23997","article-title":"Ultrastructural abnormalities and loss of myelinated fibers in the corpus callosum of demyelinated mice induced by cuprizone: ultrastructural demyelination induced by cuprizone","volume":"95","author":"Xiu","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.msard.2026.106991_bib0043","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnbeh.2010.00008","article-title":"Behavioral and neurobiological changes in C57BL\/6 mouse exposed to cuprizone: effects of antipsychotics","volume":"4","author":"Xu","year":"2010","journal-title":"Front. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.msard.2026.106991_bib0044","first-page":"31","article-title":"Recovery of behavioral changes and compromised white matter in C57BL\/6 mice exposed to cuprizone: effects of antipsychotic drugs","volume":"1","author":"Xu","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.msard.2026.106991_bib0045","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1037\/a0014477","article-title":"Behavioral and neurobiological changes in C57BL\/6 mice exposed to cuprizone","volume":"123","author":"Xu","year":"2009","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.msard.2026.106991_bib0046","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13578-017-0181-3","article-title":"Strain differences in cuprizone-induced demyelination","volume":"7","author":"Yu","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.msard.2026.106991_bib0047","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fphar.2019.00332","article-title":"Venlafaxine improves the cognitive impairment and depression-like behaviors in a cuprizone mouse model by alleviating demyelination and neuroinflammation in the brain","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.msard.2026.106991_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105489","article-title":"Valproic acid suppresses cuprizone-induced hippocampal demyelination and anxiety-like behavior by promoting cholesterol biosynthesis","volume":"158","author":"Zhu","year":"2021","journal-title":"Neurobiol. Dis."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:03:16Z","timestamp":1785754996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"alternative-id":["S2211034826000271"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.106991","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered serotonergic system and mood behaviors in a cuprizone-induced model of demyelination","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.106991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106991"}}